Generic drug makers are making greater efforts to disclose more information on their products after years of repeated requests from doctors and medical institutions, which want to better ascertain their quality and stability of their supplies.Ohara Pharmaceutical has been disclosing…
HOME > TRENDS
TRENDS
-
Industry Insiders, Healthcare Providers Call for Greater Focus on PMS by MRs, Criticize Excessive Focus on Product Promotion
December 5, 2014
-
Chugai’s Alecensa Off to a Good Start with Sales of 200 Million Yen in 1st Month
November 28, 2014
-
Bayer Sets Target of 30% Growth in Group Sales in Japan within 4 Years; Success to Depend Largely on 2 Core Products
November 21, 2014
-
Sales of Most Long-Listed Drugs Fall Short of Forecasts in Apr.-Sept.; Over 70% See Downward Revisions in Full-year Forecasts
November 11, 2014
-
Chugai Led in Research Grants Payment in FY2013; Grants Fell Among Major Drug Makers
November 5, 2014
-
Will Blopress AG Face Price War After Other Generics Debut in December?
November 5, 2014
-
Topical Combination Psoriasis Treatment Dovobet Debuts; Expected to Improve Patient QOL, Medication Adherence
October 31, 2014
-
Changes in Business Environment Spur Drug Makers to Reform Their Marketing Systems, Adopt Area Marketing Systems
October 22, 2014
-
LEP Agents Contributing to Expansion of Oral Contraceptives Market, Growing Use of Low-Dose Pill
October 10, 2014
-
Facing Unprecedented Patent Cliff for Abilify, Otsuka Holdings Sets Forth Plan to Achieve Recovery in 2018
September 24, 2014
-
Number of Females MRs Breaks 9,000 Mark with 1 in 3 in Their 20s, but Number in Management Positions Remains Low
September 19, 2014
-
With Entry of SGLT-2 Inhibitors, Competition Heating Up Again in Oral Anti-Diabetes Drug Market
September 12, 2014
-
Molecular-Targeted Treatments for Refractory Thyroid Cancer Debut, Giving Patients Hope
September 5, 2014
-
Competition Likely to Heat Up in RA Biologics Market Although Growth Continues
August 29, 2014
-
Smaller Drug Makers Actively Expanding Overseas Focus, Shedding Conventional Business Models
August 18, 2014
-
Old Giving Way to New in Osteoporosis Market as Competition among New Drugs Launched Since 2010 Increases
August 8, 2014
-
Development Activity in Pulmonary Hypertension Market Accelerates with Debut of Japan’s First CTEPH Treatment
July 23, 2014
-
Will Blopress AG Launched Prior to Patent Expiration Dominate the Market?
July 11, 2014
-
Entry of Lixiana Will Further Intensify Competition in Market for NOACs
July 4, 2014
-
With Sales of Aricept, Pariet Plummeting, Eisai to Focus on Investment in FY2014 with an Eye to Growth Track in FY2015
June 27, 2014
ページ
With Novartis’ CAR-T therapy Kymriah (tisagenlecleucel) hogging the headlines for its biggest-ever price tag in Japan, many continue to perceive high-price medicines as the main culprit of strained health finances, contending that they are driving up drug spending. But, is…
The workforce in the Japanese pharmaceutical sector is getting leaner and leaner, with the latest securities reports filed by 27 drug makers showing a 1.3% fall in their headcounts in FY2018, or 888 employees. The downtrend has been continuing since…
Riding on the back of an improved regulatory environment in China, major Japanese drug makers are moving to expand their businesses in the world’s second largest pharma market. Companies are pumping up their new drug pipelines, while forging solid sales…
As Japan heralds the new imperial era of Reiwa, Eisai CEO Haruo Naito sat with Jiho to look back on…
Japan’s generic market is hitting a plateau soon. Incentive measures rolled out by the government since 2002 have driven its…
Some seven years in the making, Japan’s Ministry of Health, Labor and Welfare (MHLW) finally rolled out a cost-effectiveness assessment…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…